10-05-2012 дата публикации
Номер: US20120115136A1
The present invention pertains to certain nucleic acid analogs and related kits that are useful for the capture, recognition, detection, identification, or quantification of certain chemical or biological entities. 1. A nucleic acid analogue for use in the capture , recognition , detection , identification or quantitation of one or more chemical or microbiological entities , which analogue is(a) a peptide nucleic acid (PNA) comprising a polyamide backbone bearing a plurality of ligands at respective spaced locations along said backbone, said ligands being each independently naturally occurring nucleobases, non-naturally occurring nucleobases or nucleobase-binding groups, each said ligand being bound directly or indirectly to a nitrogen atom in said backbone, and said ligand bearing nitrogen atoms mainly being separated from one another in said backbone by from 4 to 8 intervening atoms;(b) a nucleic acid analogue capable of hybridising to a nucleic acid of complementary sequence to form a hybrid which is more stable against denaturation by heat than a hybrid between the conventional deoxyribonucleotide corresponding to said analogue and said nucleic acid; or(c) a nucleic acid analogue capable of hybridising to a double stranded nucleic acid in which one strand has a sequence complementary to said analogue, so as to displace the other strand from said one strand.54. A nucleic acid analogue as claimed in any one of to claims 1 , incorporating or conjugated to a detectable label.6. A labelled nucleic acid analogue as claimed in claim 5 , wherein said label is a radio isotope label claim 5 , an enzyme label claim 5 , biotin claim 5 , a fluorophore claim 5 , a chemiluminescence label claim 5 , an antigen claim 5 , an antibody or a spin label.7. The use of nucleic acid analogue as defined in any one of to in the capture claim 5 , recognition claim 5 , detection claim 5 , identification or quantitation of one or more chemical or microbiological entities.86. A method of ...
Подробнее